Literature DB >> 16339099

Febuxostat--treatment for hyperuricemia and gout?

Larry W Moreland.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16339099     DOI： 10.1056/NEJMe058247

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

1.  Febuxostat: the evidence for its use in the treatment of hyperuricemia and gout.

Authors:  Angelo L Gaffo; Kenneth G Saag
Journal:  Core Evid       Date:  2010-06-15

Review 2.  Management of hyperuricemia in gout: focus on febuxostat.

Authors:  Mattheus K Reinders; Tim L Th A Jansen
Journal:  Clin Interv Aging       Date:  2010-02-02       Impact factor: 4.458

3.  A case series of allopurinol-induced toxic epidermal necrolysis.

Authors:  Harneet Ranu; Jackson Jiang; Pang Shiu Ming
Journal:  Indian J Dermatol       Date:  2011-01       Impact factor: 1.494

4.  Febuxostat: a novel agent for management of hyperuricemia in gout.

Authors:  Manisha Bisht; S S Bist
Journal:  Indian J Pharm Sci       Date:  2011-11       Impact factor: 0.975
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.